Literature DB >> 15185308

Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma.

Christoph Jüngst1, Bin Cheng, Ralph Gehrke, Volker Schmitz, Hans Dieter Nischalke, Jan Ramakers, Peter Schramel, Peter Schirmacher, Tilman Sauerbruch, Wolfgang Helmut Caselmann.   

Abstract

Accumulation of genetic alterations in hepatocarcinogenesis is closely associated with chronic inflammatory liver disease. 8-oxo-2'-deoxyguanosine (8-oxo-dG), the major promutagenic DNA adduct caused by reactive oxygen species (ROS), leads to G:C --> T:A transversions. These lesions can be enzymatically repaired mainly by human MutT homolog 1 (hMTH1), human 8-oxo-guanine DNA glycosylase (hOGG1) and human MutY homolog (hMYH). The aim of this study was to evaluate the extent of oxidative damage and its dependence on the cellular antioxidative capacity and the expression of specific DNA repair enzymes in tumor (tu) and corresponding adjacent nontumor (ntu) liver tissue of 23 patients with histologically confirmed hepatocellular carcinoma. 8-oxo-dG levels, as detected by high-pressure liquid chromatography with electrochemical detection, were significantly (P =.003) elevated in ntu tissue (median, 129 fmol/microg DNA) as compared to tu tissue (median, 52 fmol/microg DNA), and were closely associated with inflammatory infiltration. In ntu tissue, the hepatic iron concentration and malondialdehyde levels were significantly (P =.001) higher as compared to tu tissue. Glutathione content, glutathione peroxidase activity and manganese superoxide dismutase messenger RNA (mRNA) expression did not show statistical differences between ntu and tu tissue. Real-time reverse transcription polymerase chain reaction revealed in tu tissue significantly (P =.014) higher hMTH1 mRNA expression compared to ntu tissue. In contrast, hMYH mRNA expression was significantly (P <.05) higher in ntu tissue. No difference in hOGG1 mRNA expression was seen between tu and ntu. In conclusion, these data suggest that ROS generated by chronic inflammation contribute to human hepatocarcinogenesis. The role of DNA repair enzymes appears to be of reactive rather than causative manner.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15185308     DOI: 10.1002/hep.20241

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  47 in total

1.  Modulation of AP-endonuclease1 levels associated with hepatic cirrhosis in rat model treated with human umbilical cord blood mononuclear stem cells.

Authors:  Ahmad R Bassiouny; Amira Z Zaky; Shaymaa A Abdulmalek; Kamal M Kandeel; Alaa Ismail; Marie Moftah
Journal:  Int J Clin Exp Pathol       Date:  2011-10-16

2.  Long-distance inflammatory and genotoxic impact of cancer in vivo.

Authors:  Jiri Bartek; Martin Mistrik; Jirina Bartkova
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-06       Impact factor: 11.205

3.  Association of hOGG1 Ser326Cys polymorphism with susceptibility to hepatocellular carcinoma.

Authors:  Jun Guo; Jing Yang; Yan Li
Journal:  Int J Clin Exp Med       Date:  2015-06-15

4.  Gene expression profile related to the progression of preneoplastic nodules toward hepatocellular carcinoma in rats.

Authors:  Julio Isael Pérez-Carreón; Cristina López-García; Samia Fattel-Fazenda; Evelia Arce-Popoca; Leticia Alemán-Lazarini; Sergio Hernández-García; Véronique Le Berre; Sergueï Sokol; Jean Marie Francois; Saúl Villa-Treviño
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

Review 5.  Hepatitis B virus-induced oncogenesis.

Authors:  Joachim Lupberger; Eberhard Hildt
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 6.  Pathophysiological basis for antioxidant therapy in chronic liver disease.

Authors:  Jesús Medina; Ricardo Moreno-Otero
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 7.  Oxidative DNA damage caused by inflammation may link to stress-induced non-targeted effects.

Authors:  Carl N Sprung; Alesia Ivashkevich; Helen B Forrester; Christophe E Redon; Alexandros Georgakilas; Olga A Martin
Journal:  Cancer Lett       Date:  2013-09-14       Impact factor: 8.679

Review 8.  Hepatic iron overload and hepatocellular carcinoma.

Authors:  Michael C Kew
Journal:  Liver Cancer       Date:  2014-03       Impact factor: 11.740

Review 9.  Glutathione levels in human tumors.

Authors:  Michael P Gamcsik; Mohit S Kasibhatla; Stephanie D Teeter; O Michael Colvin
Journal:  Biomarkers       Date:  2012-08-20       Impact factor: 2.658

10.  Amelioration of carcinogen-induced toxicity in mice by administration of a potentized homeopathic drug, natrum sulphuricum 200.

Authors:  Nandini Bhattacharjee; Surajit Pathak; Anisur Rahman Khuda-Bukhsh
Journal:  Evid Based Complement Alternat Med       Date:  2007-06-19       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.